Patent classifications
C12R2001/00
Probiotic formulation for reducing stress, anxiety and depression
Stress is any demand placed on the brain or physical body, thereby leading to anxiety and depression and it is a common phenomenon experienced by humans and animals. Stress, anxiety and depression often leads to serious mental ill health. People with anxiety disorders respond to certain things or situations with fear and dread and display physical signs such as a pounding heart and sweating. Often, people lose their willpower, concentration and interest in day to day activities, are drained of energy and can even become devoid of any emotion.
It is documented that low activity of certain neurotransmitters can result in anxiety, chronic stress, depression, difficulty in concentrating, memory problems, muscle pain, headaches, insomnia and sleep problems. Therefore, if the level of these neurotransmitters is raised, the problem of stress, anxiety and depression can be cured. The invention describes a formulation to naturally increase the levels of certain neurotransmitters in the body, thereby reducing stress, anxiety and depression.
Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates
Disclosed are methods, systems, components, and compositions for cell-free synthesis of glycosylated proteins. The glycosylated proteins may be utilized in vaccines, including anti-bacterial vaccines. The glycosylated proteins may include a bacterial polysaccharide conjugated to a carrier, which may be utilized to generate an immune response in an immunized host against the polysaccharide conjugated to the carrier. The glycosylated proteins may be synthesized in cell-free glycoprotein synthesis (CFGpS) systems using prokaryote cell lysates that are enriched in components for glycoprotein synthesis such as oligosaccharyltransferases (OSTs) and lipid-linked oligosaccharides (LLOs) including OSTs and LLOs associated with synthesis of bacterial O antigens.
Process for providing a culture of microorganisms to an elongated element
The present invention relates to a process for depositing at least a culture of microorganisms to an elongated element, preferably a yarn, comprising the steps of: providing at least a first feeding device comprising at least a first outlet; supplying at least one elongated element to said at least first feeding device; feeding to said first outlet at least a first culture comprising at least one microorganism; dispensing said first culture from said at least first outlet; contacting at least part of said elongated element with said first culture of microorganisms, to provide at least a part of said elongated element with an amount of said first culture of microorganisms.
METHOD FOR CONTROLLED PRODUCTION OF GLYCERIC ACID
A method for controlled production of glyceric acid includes, during the glyceric acid fermentation process, real-time online monitoring of at least one of the respiratory quotient and redox potential in the fermentation liquid as well as the fermentation process specific growth rate, and controlling their values within the following ranges: 0.1˜1.5 for respiratory quotient, −300˜50 mV for redox potential, 0.05˜0.8 for specific growth rate. Process parameters for this method are controlled within predetermined ranges by online monitoring at least one of respiratory quotient (RQ) and redox potential as well as the specific growth rate in the fermentation process, thereby meeting the growth requirements of bacteria, effectively promoting the glycerol metabolism and synthesis and improving the conversion rate.
COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING A BACTERIAL EXTRACELLULAR PRODUCT FROM PSEUDOALTEROMONAS ANTARCTICA, AND USE THEREOF
Extract of a bacterial strain for its use in treatment and/or care of the skin and/or mucous membranes, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, its use for sebum reduction and skin firmness.
NATURAL LACTIC ACID BACTERIA ISOLATED FROM KOREAN TRADITIONAL NURUK TO BE USED FOR BAKERY
Provided is Lactobacillus curvatus SPC-SNU 70-3 (KCTC 12778BP) which is novel natural Korean lactic acid bacteria isolated from traditional Korean nuruk.
Bio-Nematocide
The present invention provides for a bio-nematocide for repairing damage to wood and related cellulosic products caused by nematodes.
INSECTICIDAL EFFECT BASED ON A MODIFICATION OF THE BACTERIA OF THE GENUS GLUCONACETOBACTER
An insecticidal composition wherein the composition has an insecticidal effect based a modification of the bacteria of the genus gluconacetobacter. The Insecticidal effect show activity against Green peach aphid (Myzus persicae (Sulzer)); Western flower thrips (Frankliniella occidentalis) on peaches and Citrus woolly whitefly (Aleurothrixus floccosus) on citrus.
Isolated Bacterial Strain of the Genus Burkholderia and Pesticidal Metabolites Therefrom
A species of Burkholderia sp with no known pathogenicity to vertebrates but with pesticidal activity (e.g., plants, insects, fungi, weeds and nematodes) is provided. Also provided are natural products derived from a culture of said species and methods of controlling pests using said natural products.
NOVEL CYSTOBACTAMIDES
The present invention provides cystobactamides of formula (I) and the use thereof for the treatment or prophylaxis of bacterial infections.
##STR00001##